The pharmaceutical packaging market size is estimated to be worth USD 112.3 billion in 2025 and is anticipated to reach a value of USD 153.9 billion by 2035. Sales are projected to rise at a CAGR of 3.2% over the forecast period between 2025 and 2035. The revenue generated by pharmaceutical packaging in 2024 was USD 109.5 billion.
Among variety or product types, bottles will lead the market for pharmaceutical packaging with market share over 34% in the assessment period. Bottles are the most widely used product type in pharmaceutical packaging, primarily for liquid formulations (syrups, suspensions), tablets, and capsules. They are favored for their durability, ease of storage, and cost-effectiveness. Commonly made from plastic or glass, bottles are used in over-the-counter drugs, prescription medications, and pediatric formulations globally.
Pharmaceutical Packaging Industry Forecast
| Attributes | Key Insights |
|---|---|
| Historical Size, 2024 | USD 109.5 billion |
| Estimated Size, 2025 | USD 112.3 billion |
| Projected Size, 2035 | USD 153.9 billion |
| Value-based CAGR (2025 to 2035) | 3.2% |
Plastic is the most used material compared to others in pharmaceutical packaging because it is lightweight, cost-effective, durable, and versatile. It offers excellent protection against moisture and contamination and can be molded into various formats like bottles, blisters, and pouches. Due to these factors plastic is expected to dominate with a market share of more than 59% in the material segment in upcoming years.
The market of market will witness profitable growth during the forecast period. It is expected to create an incremental opportunity of USD 44.4 billion and grow by 1.4 times its current value by 2035.
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
The below table presents the expected CAGR for the global pharmaceutical packaging market over several semi-annual periods spanning from 2025 to 2035.
| Particular | Value CAGR |
|---|---|
| H1 | 2.9% (2024 to 2034) |
| H2 | 3.6% (2024 to 2034) |
| H1 | 3.5% (2025 to 2035) |
| H2 | 4.4% (2025 to 2035) |
In the first half (H1) of the decade from 2024 to 2034, the business is predicted to surge at a CAGR of 2.9%, followed by a slightly higher growth rate of 3.6% in the second half (H2) of the same decade. Moving into the subsequent period, from H1 2025 to H2 2035, the CAGR is projected to decrease slightly to 3.5% in the first half and remain relatively moderate at 4.4% in the second half. In the first half (H1) the market witnessed a decrease of 60 BPS while in the second half (H2), the market witnessed an increase of 80 BPS.
Increase in Pharmaceutical Products Demand from Aging Population & Rise in Chronic Diseases
Increase in the global healthcare sector's demand is the main driver of this pharmaceutical packaging market. The world's increasing population is ageing, and this tends to have more medication requirements among elderly people. This amount of demand is also fueled by the increasing chronic diseases such as diabetes, hypertension, and cancer, which demand long-term medication compliance.
Such conditions require safe packaging of drugs for the safety and convenience of the patient. The package must not allow the medicine to be affected by damage, contamination, or degradation; simultaneously, easy for patients to use. All these are the contributing factors to the rising demand for pharmaceutical packaging innovations across the globe
Increased Packaging Demand Due to Rise in Biologics & Injectable Drugs
A change towards biologics, biosimilars, and injectable drugs influences the pharmaceutical packaging market quite significantly as it demands custom-made packaging that ensures security and efficacy in use. Biologics are composed of living cells and sensitive to temperature and contamination, therefore requiring the packaging environment to be sterile and protecting it against temperature extremes when in storage and during transportation.
Self-administered doses of biologics and vaccines are increasingly being placed in a pre-filled syringe, pen, and auto injector form. Such devices require packaging that protects contents and, simultaneously, keeps the products easy to use, sterile, and safe for patients. Thus, as biologics and injectable become more popular, there is an ever-growing need for innovative and secure packaging solutions that will support these products.
Strict Food Safety Regulations and Volatile Raw Material Cots May Impact Market Growth
Pharmaceutical packaging sensitive products such as injectable and biologics demands a packaging with advanced sterility and quality. To provide safety and efficiency in a product, sophisticated packaging technology can protect from the entry of germs into a package, retain its stability, and preserve integrity. Specialized facilities and equipment must be used for manufacturing, and rigorous testing is necessary to confirm that the packaging meets required specifications.
These factors add complexity to the manufacturing process, sometimes costing more money to the manufacturers. The stringent requirements may also limit some materials or designs, complicating the whole development and production process for packaging.
The global pharmaceutical packaging market recorded a CAGR of 2.5% during the historical period between 2020 and 2024. Market growth of pharmaceutical packaging was positive as it reached a value of USD 109.5 billion in 2024 from USD 98.9 billion in 2020.
In the historic period, pharmaceutical packaging sales have increased gradually with rising health care needs and advances in medicines. Some innovations that came in were blister packs, tamper-proof seals, and pre-filled syringes. The rising need for chronic disease treatments and growing access to health care in developing regions substantially increased the demand for advanced and reliable packaging solutions.
Looking ahead, further growth of the pharmaceutical packaging industry will come from demand in personalized medicine and biologics. Sustainable and smart packaging solutions - eco-friendly materials and digital tracking features - are increasingly being looked for to alleviate concerns about environmental factors and ensure that the global supply chain remains as efficient as possible for pharmaceutical products.
Tier 1 companies comprise market leaders capturing significant market share in global market. These market leaders are characterized by high production capacity and a wide product portfolio. These market leaders are distinguished by their extensive expertise in manufacturing across multiple packaging formats and a broad geographical reach, underpinned by a robust consumer base.
They provide a wide range of series including recycling and manufacturing utilizing the latest technology and meeting the regulatory standards providing the highest quality. Prominent companies within tier 1 include Amcor Plc, Ardagh Group S.A., Berry Global Group, Inc., Catalent, Inc., West Pharmaceutical Services, Inc among others.
Tier 2 companies include mid-size players having presence in specific regions and highly influencing the local market. These are characterized by a strong presence overseas and strong market knowledge. These market players have good technology and ensure regulatory compliance but may not have advanced technology and wide global reach.
Prominent companies in tier 2 include Bilcare Limited, Constantia Flexibles Group GmbH, Gerresheimer AG, Bormioli Pharma S.p.A., Schott AG, CCL Container (CCL Industries), UFlex Limited, SGD Pharma, Comar, LLC, and Huhtamaki Oyj.
Tier 3 includes the majority of small-scale companies operating at the local presence and serving niche markets. These companies are notably oriented towards fulfilling local market demands and are consequently classified within the tier 3 share segment. They are small-scale players and have limited geographical reach. Tier 3, within this context, is recognized as an unorganized market, denoting a sector characterized by a lack of extensive structure and formalization when compared to organized competitors.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
The section below covers the future forecast for the pharmaceutical packaging market in terms of countries. Information on key countries in several parts of the globe, including North America, Latin America, East Asia, South Asia and Pacific, Western Europe, Eastern Europe and MEA is provided. USA is anticipated to remain at the forefront in North America, with a CAGR of 2.9% through 2035. In Europe, Germany is projected to witness a CAGR of 2.4% by 2035.
| Countries | Value CAGR (2025 to 2035) |
|---|---|
| USA | 2.9% |
| Germany | 2.4% |
| China | 4.2% |
| UK | 2.1% |
| Spain | 2.6% |
| India | 5.4% |
| Canada | 2.7% |
The USA has one of the highest per capita healthcare expenses in the world, which naturally supports the market growth of the pharmaceutical packaging segment. A lot of the USA population relies heavily on prescription medication and over-the-counter drugs which means that they require safe yet effective packaging options.
Advanced healthcare infrastructure and insurance systems ensure that medications keep flowing steadily to the patients, necessitating innovative packaging to cater to the patient's needs. This includes special packaging for biologics, chronic disease treatment, and high-value drugs. Patient safety and tamper evidence along with a strict FDA regulation are a few of the reasons that promote high-quality innovative packaging in the pharmaceutical sector of the USA
In the UK, post-Brexit regulations impose new regulatory demands on pharmaceutical packaging. It requires packaging acceptable to both UK and European Union markets. This means labelling, safety, and serialization rules that call for adaptation on the part of the packaging. Also, with an aging population, patient-friendly packaging in the UK is in increasing demand.
Elderly patients rely majorly on medicines for chronic illnesses, so packaging and usage need to be simplified. Ease of use, specifically in packaging designs, like blister packs and pre-measured amounts, would support improving adherence and user convenience. Such factors as demand for environment-friendly and secure packaging are now shaping the UK pharmaceutical packaging market.
The section contains information about the leading segments in the industry. In terms of material, plastic is estimated to account for a share over 40% by 2035. By thickness, 80-150 µm are projected to dominate by holding a share of 42.4% by the end 2035.
| Material | Plastic |
|---|---|
| Market Share (2035) | 41.2% |
Plastic is utilized for pharmaceutical packaging as it is low-cost, hard, and flexible. This involves materials such as HDPE or High-Density Polyethylene, used in bottles holding liquid drugs since the material resists moisture and chemical exposure ensuring safe contents. Polyethylene Terephthalate is also used in prefilled syringes as PET maintains transparency and prevents degradation of injectable as it's really sensitive in products.
Apart from that, plastic has other advantages including its light weight, easy ability to be molded to many shapes and resistance to breakage. Moreover, it has the advantage of mass production with high volume distributed all over the world.
| Thickness | 80-150 µm |
|---|---|
| Market Share (2035) | 42.4% |
Bottles are a common type of pharmaceutical packaging for the reason that excellent protection is made available to several forms of drug, such as liquids, tablets, and capsules. Pharmaceutical firms prefer bottles in order to offer protection to a medication from moisture as well as from air, providing stability and potency.
Bottles are easy to design with features like child-resistant caps and tamper-evident seals, addressing safety concerns. These adapt well to small sizes up to bigger bottles and hence find great utility for OTC and prescription medicines. Besides, clear labeling through bottles can assure full compliance with rigorous standards required in regulations and increases their use in the pharmaceutical world.
Key players of pharmaceutical packaging industry are developing and launching new products in the market. They are integrating with different firms and extending their geographical presence. Few of them are also collaborating and partnering with local brands and start-up companies for new product development.
Key Developments in Pharmaceutical Packaging Market
Various product types in pharmaceutical packaging include bottles, vials & ampoules, blister, bags & pouches, prefilled syringes and cartridges, sachets, trays, tubes, and containers, jars, and others,
In terms of material, the market of pharmaceutical packaging is divided into plastic, paper, metal and glass. Plastic further include polyethylene, polypropylene, polyvinyl chloride, Polyethylene terephthalate, polystyrene and others. Polyethylene is sub-segmented into HDPE and LDPE.
In terms of drug delivery, the market for pharmaceutical packaging is segmented into ophthalmic, injectable, IV drugs, nasal, wound care, pulmonary, oral, and others (topical and transdermal treatments)
Key countries of North America, Latin America, East Asia, South Asia and Pacific, Western Europe, Eastern Europe, Middle East and Africa are covered.
The pharmaceutical packaging industry is projected to witness CAGR of 3.2% between 2025 and 2035.
The global pharmaceutical packaging industry stood at USD 109.5 billion in 2024.
Global pharmaceutical packaging industry is anticipated to reach USD 153.9 billion by 2035 end.
South Asia & Pacific is set to record a CAGR of 5.8% in assessment period.
The key players operating in the pharmaceutical packaging industry are include Amcor Plc, Ardagh Group S.A., Berry Global Group, Inc., Catalent, Inc., West Pharmaceutical Services, Inc among others.
| Market Size (2024) | USD 4.8 billion |
|---|---|
| Market Value (2034) | USD 7.7 billion |
| Market Projected Growth Rate (2024 to 2034) | 4.8% CAGR |
| Market Size (2024) | USD 75,527.4 million |
|---|---|
| Anticipated Market Value (2034) | USD 290,824.8 million |
| Projected CAGR (2024 to 2034) | 14.4% |
| Estimated Market Share in 2023 | USD 6.1 billion |
|---|---|
| Forecasted Market Size by 2033 | USD 11.9 billion |
| Projected Market Growth Rate from 2023 to 2033 | 7.5% CAGR |
| Market Size (2023) | USD 484.8 million |
|---|---|
| Projected Market Value (2033) | USD 812.5 million |
| Market CAGR (2023 to 2033) | 5.3% |
Explore Healthcare Packaging Insights
View Reports
Pharmaceutical Packaging Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
